Medicaments for the treatment of chronic obstructive pulmonary disease


Ontology type: sgo:Patent     


Patent Info

DATE

2010-06-01T00:00

AUTHORS

KONETZKI INGO , SCHROMM KURT , SCHOLLENBERGER HERMANN , PESTEL SABINE , SCHNAPP ANDREAS , BOUYSSOU THIERRY , BUETTNER FRANK , HEINE CLAUDIA , LUSTENBERGER PHILIPP , HOENKE CHRISTOPH , RUDOLF KLAUS

ABSTRACT

A pharmaceutical composition comprising a compound of formula 1 wherein: n is 1 or 2;R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;R2 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;R3 is hydrogen, C1-C4-alkyl, OH, halogen, —O—C1-C4-alkyl, —O—C1-C4-alkylene-COOH, or —O—C1-C4-alkylene-CO—O—C1-C4-alkyl, oran acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; anda pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD). More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/40", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/34", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "KONETZKI INGO", 
        "type": "Person"
      }, 
      {
        "name": "SCHROMM KURT", 
        "type": "Person"
      }, 
      {
        "name": "SCHOLLENBERGER HERMANN", 
        "type": "Person"
      }, 
      {
        "name": "PESTEL SABINE", 
        "type": "Person"
      }, 
      {
        "name": "SCHNAPP ANDREAS", 
        "type": "Person"
      }, 
      {
        "name": "BOUYSSOU THIERRY", 
        "type": "Person"
      }, 
      {
        "name": "BUETTNER FRANK", 
        "type": "Person"
      }, 
      {
        "name": "HEINE CLAUDIA", 
        "type": "Person"
      }, 
      {
        "name": "LUSTENBERGER PHILIPP", 
        "type": "Person"
      }, 
      {
        "name": "HOENKE CHRISTOPH", 
        "type": "Person"
      }, 
      {
        "name": "RUDOLF KLAUS", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002018-200427040-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008046870", 
          "https://doi.org/10.2165/00002018-200427040-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200427100-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048743769", 
          "https://doi.org/10.2165/00002018-200427100-00001"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-06-01T00:00", 
    "description": "

A pharmaceutical composition comprising a compound of formula 1

\n

\"embedded
\nwherein:\n

  • n is 1 or 2;
  • R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;
  • R2 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;
  • R3 is hydrogen, C1-C4-alkyl, OH, halogen, —O—C1-C4-alkyl, —O—C1-C4-alkylene-COOH, or —O—C1-C4-alkylene-CO—O—C1-C4-alkyl, or
  • an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and
  • a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD).

", "endDate": "2027-01-19", "id": "sg:patent.US-7727984-B2", "name": "Medicaments for the treatment of chronic obstructive pulmonary disease", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420061.1", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7727984-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-11-24T21:23", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/patent/patent_46.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7727984-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7727984-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7727984-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7727984-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

77 TRIPLES      15 PREDICATES      19 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7727984-B2 schema:about anzsrc-for:34
2 anzsrc-for:3402
3 anzsrc-for:40
4 schema:author Na5e11b4862b7422885c4845fb870907b
5 schema:citation sg:pub.10.2165/00002018-200427040-00003
6 sg:pub.10.2165/00002018-200427100-00001
7 schema:datePublished 2010-06-01T00:00
8 schema:description <p id="p-0001" num="0000">A pharmaceutical composition comprising a compound of formula 1</p> <p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="29.80mm" wi="71.88mm" file="US07727984-20100601-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US07727984-20100601-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US07727984-20100601-C00001.MOL"/></attachments></chemistry><br/> wherein: <ul><li id="ul0001-0001" num="0000">n is 1 or 2;</li><li id="ul0001-0002" num="0000">R<sup>1 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, halogen, OH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl;</li><li id="ul0001-0003" num="0000">R<sup>2 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, halogen, OH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl;</li><li id="ul0001-0004" num="0000">R<sup>3 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, OH, halogen, &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl, &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkylene-COOH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkylene-CO&#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl, or</li><li id="ul0001-0005" num="0000">an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and</li><li id="ul0001-0006" num="0000">a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD).</li></ul></p>
9 schema:endDate 2027-01-19
10 schema:name Medicaments for the treatment of chronic obstructive pulmonary disease
11 schema:recipient grid-institutes:grid.420061.1
12 schema:sameAs https://app.dimensions.ai/details/patent/US-7727984-B2
13 schema:sdDatePublished 2022-11-24T21:23
14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
15 schema:sdPublisher N09c429f504f7428b85ba65e44b967a7e
16 sgo:license sg:explorer/license/
17 sgo:sdDataset patents
18 rdf:type sgo:Patent
19 N015d4e176a1c4cc092aec7e5e42cdd65 schema:name HOENKE CHRISTOPH
20 rdf:type schema:Person
21 N07dc807e259d47388b87ac2a39bbc291 rdf:first N015d4e176a1c4cc092aec7e5e42cdd65
22 rdf:rest N8c4c5caf7a4c4ec584d5e9d881b45767
23 N09c429f504f7428b85ba65e44b967a7e schema:name Springer Nature - SN SciGraph project
24 rdf:type schema:Organization
25 N0e1ceb2992fa43978a529099017e9fca rdf:first N782fab6e41744b9da424743fedec83a8
26 rdf:rest N3ea0c82370ee47eba9ee64619256af37
27 N31fa3524fbdf4bc9b561536868c58071 schema:name BOUYSSOU THIERRY
28 rdf:type schema:Person
29 N3ea0c82370ee47eba9ee64619256af37 rdf:first Nb48a2998f28e46bcbede29b2272246b2
30 rdf:rest Ne34e009b7e9f4743a40ddf3a0268d878
31 N4b57fa7ce7d4446a9a2cf2d74412ed88 schema:name KONETZKI INGO
32 rdf:type schema:Person
33 N58ac2a9c9b7e49d7abb3405c458f3ac4 rdf:first Na84221f8f45949febf75c84646be9ba4
34 rdf:rest N91e6e07aa733462abb09ca983fd079ba
35 N6e9a50db0de6492facf893a566467bd6 schema:name BUETTNER FRANK
36 rdf:type schema:Person
37 N782fab6e41744b9da424743fedec83a8 schema:name PESTEL SABINE
38 rdf:type schema:Person
39 N8c4c5caf7a4c4ec584d5e9d881b45767 rdf:first N9f6ae94c416446c49980cbc7ae027c77
40 rdf:rest rdf:nil
41 N90d6ba001e0a4515b2220e13283aa82d schema:name SCHOLLENBERGER HERMANN
42 rdf:type schema:Person
43 N91e6e07aa733462abb09ca983fd079ba rdf:first N90d6ba001e0a4515b2220e13283aa82d
44 rdf:rest N0e1ceb2992fa43978a529099017e9fca
45 N9f6ae94c416446c49980cbc7ae027c77 schema:name RUDOLF KLAUS
46 rdf:type schema:Person
47 Na5e11b4862b7422885c4845fb870907b rdf:first N4b57fa7ce7d4446a9a2cf2d74412ed88
48 rdf:rest N58ac2a9c9b7e49d7abb3405c458f3ac4
49 Na84221f8f45949febf75c84646be9ba4 schema:name SCHROMM KURT
50 rdf:type schema:Person
51 Naa209b4a65f24ff99f3751a3761b025b rdf:first Nc3ecb9e03c6640d886dd8b8e431b863c
52 rdf:rest Ne47efaebf0e94a7a9f21213e10caaa63
53 Nad26e5327a5c483aa77c21578210b5bf rdf:first N6e9a50db0de6492facf893a566467bd6
54 rdf:rest Naa209b4a65f24ff99f3751a3761b025b
55 Nb48a2998f28e46bcbede29b2272246b2 schema:name SCHNAPP ANDREAS
56 rdf:type schema:Person
57 Nb4f18c92d20149ebb090bf9712893a9b schema:name LUSTENBERGER PHILIPP
58 rdf:type schema:Person
59 Nc3ecb9e03c6640d886dd8b8e431b863c schema:name HEINE CLAUDIA
60 rdf:type schema:Person
61 Ne34e009b7e9f4743a40ddf3a0268d878 rdf:first N31fa3524fbdf4bc9b561536868c58071
62 rdf:rest Nad26e5327a5c483aa77c21578210b5bf
63 Ne47efaebf0e94a7a9f21213e10caaa63 rdf:first Nb4f18c92d20149ebb090bf9712893a9b
64 rdf:rest N07dc807e259d47388b87ac2a39bbc291
65 anzsrc-for:34 schema:inDefinedTermSet anzsrc-for:
66 rdf:type schema:DefinedTerm
67 anzsrc-for:3402 schema:inDefinedTermSet anzsrc-for:
68 rdf:type schema:DefinedTerm
69 anzsrc-for:40 schema:inDefinedTermSet anzsrc-for:
70 rdf:type schema:DefinedTerm
71 sg:pub.10.2165/00002018-200427040-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008046870
72 https://doi.org/10.2165/00002018-200427040-00003
73 rdf:type schema:CreativeWork
74 sg:pub.10.2165/00002018-200427100-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048743769
75 https://doi.org/10.2165/00002018-200427100-00001
76 rdf:type schema:CreativeWork
77 grid-institutes:grid.420061.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...